Mutations in TP53 increase the risk of SOX2 copy number alterations and silencing of TP53 reduces SOX2 expression in non-small cell lung cancer
Crossref DOI link: https://doi.org/10.1186/S12885-016-2061-3
Published: 2016-12
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Samulin Erdem, Johanna
Skaug, Vidar
Bakke, Per
Gulsvik, Amund
Haugen, Aage
Zienolddiny, Shanbeh
unspecified valid from 2016-01-19